Holen Sie sich die Stockscreener-App
8.89
3.53%
0.30
Schlusskurs vom Vortag:
$8.59
Offen:
$8.59
24-Stunden-Volumen:
73,609
Relative Volume:
0.23
Marktkapitalisierung:
$318.57M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+14.01%
1M Leistung:
+67.79%
6M Leistung:
+128.02%
1J Leistung:
-51.77%
1-Tages-Spanne:
$8.44
$8.91
1-Wochen-Bereich:
$7.84
$8.98
52-Wochen-Spanne:
$2.88
$20.37
Bioage Labs Inc Stock (BIOA) Company Profile
Firmenname
Bioage Labs Inc
Sektor
Telefon
510-806-1445
Adresse
5885 HOLLIS STREET, EMERYVILLE
Vergleichen Sie BIOA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIOA
Bioage Labs Inc
|
8.885 | 307.99M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
121.07 | 51.07B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.30 | 44.42B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.865 | 42.75B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.20 | 27.86B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
473.15 | 20.44B | 3.08B | 1.24B | 1.07B | 25.61 |
Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-02-28 | Eingeleitet | William Blair | Mkt Perform |
| 2024-12-10 | Herabstufung | Morgan Stanley | Overweight → Underweight |
| 2024-12-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-12-09 | Herabstufung | Jefferies | Buy → Hold |
| 2024-10-21 | Eingeleitet | Citigroup | Buy |
| 2024-10-21 | Eingeleitet | Jefferies | Buy |
| 2024-10-21 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Bioage Labs Inc Aktie (BIOA) Neueste Nachrichten
Is BioAge Labs Inc. (Y7G) stock supported by free cash flowPortfolio Growth Summary & Weekly Chart Analysis and Trade Guides - newser.com
Is BioAge Labs Inc. stock recession proofStop Loss & Free Weekly Watchlist of Top Performers - newser.com
Will BioAge Labs Inc. (Y7G) stock hit analyst forecastsBuy Signal & Expert Curated Trade Ideas - newser.com
Is BioAge Labs Inc. (Y7G) stock a buy on weakness2025 Short Interest & Risk Adjusted Buy and Sell Alerts - newser.com
How interest rate cuts could boost BioAge Labs Inc. stock2025 Earnings Impact & Accurate Intraday Trading Signals - newser.com
Is BioAge Labs Inc. stock a buy before product launchesMarket Volume Report & Weekly Top Stock Performers List - newser.com
How to use Fibonacci retracement on BioAge Labs Inc.Gap Up & Verified Stock Trade Ideas - newser.com
Order flow analysis tools used on BioAge Labs Inc.Entry Point & Low Risk Entry Point Tips - newser.com
Will BioAge Labs Inc. (Y7G) stock sustain uptrend momentumTrade Analysis Report & Daily Risk Controlled Trade Plans - newser.com
How BioAge Labs Inc. (Y7G) stock stacks up against competitorsQuarterly Portfolio Report & Safe Capital Growth Tips - newser.com
How supply shortages influence BioAge Labs Inc. (Y7G) stockJuly 2025 Macro Moves & Capital Efficiency Focused Ideas - newser.com
Top 3 Biotech Stocks Capitalizing on the AI Revolution - Investing.com India
BIOA: NLRP3 inhibitor targets cardiovascular risk in obesity; APJ agonist INDs planned next year - TradingView
BioAge Labs (BIOA) Price Target Increased by 20.83% to 9.86 - Nasdaq
BioAge Labs Inc. stock trendline breakdownGold Moves & Fast Entry Momentum Trade Alerts - newser.com
Can BioAge Labs Inc. stock resist sector downturnsWeekly Profit Analysis & Free Weekly Chart Analysis and Trade Guides - newser.com
Published on: 2025-11-15 16:22:46 - newser.com
Finanzdaten der Bioage Labs Inc-Aktie (BIOA)
Es liegen keine Finanzdaten für Bioage Labs Inc (BIOA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.93%
0.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):